Результаты поиска - Lijin Zhao

  • Отображение 1 - 3 результаты of 3
Отмена результатов
  1. 1
    Significant Response to Palbociclib Plus Lenvatinib as Second-line Treatment for CDKN2A/2B Deletion Intrahepatic Cholangiocarcinoma: A Case Report

    Significant Response to Palbociclib Plus Lenvatinib as Second-line Treatment for CDKN2A/2B Deletion Intrahepatic Cholangiocarcinoma: A Case Report по Kai Liu, Ziyue Huang, Lijin Zhao, Haitao Zhao

    Опубликовано 2025
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  2. 2
    TLR9 regulates NLRP3 inflammasome activation via the NF-kB signaling pathway in diabetic nephropathy

    TLR9 regulates NLRP3 inflammasome activation via the NF-kB signaling pathway in diabetic nephropathy по Jin-feng Shen, Zaiyou Dai, Yunsheng Li, Huiping Zhu, Lijin Zhao

    Опубликовано 2022
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  3. 3
    Immunotherapy in hepatocellular carcinoma: an overview of immune checkpoint inhibitors, drug resistance, and adverse effects

    Immunotherapy in hepatocellular carcinoma: an overview of immune checkpoint inhibitors, drug resistance, and adverse effects по Xuan-Yu Gu, Jinlong Huo, Zhiyong Yu, Ji-Chang Jiang, Yaxuan Xu, Lijin Zhao

    Опубликовано 2024
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: